TG Therapeutics, Inc. (TGTX)
30.58
+1.05
(+3.56%)
USD |
NASDAQ |
Feb 23, 16:00
30.74
+0.16
(+0.52%)
After-Hours: 19:59
TG Therapeutics Market Cap : 4.855B for Feb. 23, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Amicus Therapeutics, Inc. | 4.505B |
| MannKind Corp. | 1.710B |
| Keros Therapeutics, Inc. | 478.62M |
| ACADIA Pharmaceuticals, Inc. | 4.184B |
| Alnylam Pharmaceuticals, Inc. | 43.68B |
Market Cap Related Metrics
| PE Ratio | 11.01 |
| PS Ratio | 9.293 |
| Price to Book Value | 7.995 |
| Price | 30.58 |
| Earnings Yield | 9.08% |
| Operating PE Ratio | 48.09 |
| Normalized PE Ratio | 11.00 |